Skip to content
Precision for Medicine
Contact Us
Breaking News

Precision Wins Fierce CRO Award for Innovative Solutions in Drug Development

Read more
Americas-Hero image Americas-Hero image

Precision Americas CRO Services

Collaborate with the best-in-class researchers. Execute your trials with Precision.
At Precision, pathbreaking research is part of our DNA and what truly distinguishes us in the industry. Through Precision's Americas CRO services, you gain access to the world’s most prominent research institutions and experts who are globally renowned in their fields. Regardless of the complexity involved, we are dedicated to achieving your objective of delivering innovative treatments that meet unmet patient needs, more efficiently and intelligently than ever before.
Americas_Map_Final

Precision Americas CRO Services- Pioneering cutting-edge research 

Headquartered in the United States for over two decades, Precision’s reputation is rooted in the strong and enduring relationships we've cultivated over time. Our strategic collaborations with leading researchers across the United States and Canada, have enabled us to optimally advance even the most challenging clinical development programs.

Our integrated clinical development, biomarker expertise, and regulatory, capabilities seamlessly combine to deliver unique value to our clients through their clinical development journey in the Americas.

FSP Governance

A reputation built on success and precision

 Precision’s track record across the Americas is backed by the successful approval of multiple products supported through the years. We have diligently worked towards being recognized as a partner with top-tier clinical research expertise, assisting you in achieving operational efficiency, providing timely insights for informed decision-making, and ultimately expediting regulatory submissions.

20 Offices across the Americas
2350 Experts across the region
5 Precision labs for integrated clinical development

The Precision team driving your success in the Americas

  • Simon-Fleming

    Simon Fleming

    Executive Vice President

  • SallyAnne Williams

    Sallyanne Williams

    Senior Vice President, Global Head Project Management

  • Nithiyanandhan-Ananthakrishnan-1

    Nithiya Ananthakrishnan

    Senior Vice President, Biometrics

  • Teresa-Pokladowski-300x300

    Teresa Pokladowski

    Regional Vice President, Clinical Business Solutions, North America

  • Sheila-Antonio

    Sheila Antonio

    Vice President, Clinical Data Management

Streamlined models for an ever-changing environment

With Precision's robust presence across the Americas, you have a strong and unified team to respond to any changes in the clinical and regulatory environment in the course of your development lifecycle.

  • Explore

    Full-Service Outsourcing

    Navigating your clinical development program from strategic planning through meticulous execution to a successful regulatory submission.

    Explore
  • Explore

    Precision FSP

    Building agile expert teams across geographies to help you tide over tight development and submission timelines.

    Explore

Explore the latest insights from Precision’s experts

Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to achieve expedited trial outcomes across the Americas.

 

Explore our blog
Read: Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss

Clinical Trials - Oncology - Cell Therapies

Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1716454310949, hs_published_at=1748379090824, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins-White-150x150.jpeg',altText='Alexis-Hobbins-White-150x150',fileId=164710912635}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White
Discover
Read: Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

Clinical Trials

Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kurt Preugschat avatar

    Kurt Preugschat
Discover
Read: Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM) Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

Clinical Trials

Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kurt Preugschat avatar

    Kurt Preugschat
Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore

Simon-Fleming
Simon Fleming

Executive Vice President

Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.
SallyAnne Williams
Sallyanne Williams

Senior Vice President, Global Head Project Management

Long-standing project management leader dedicated to improving delivery across all phases of product development. Working on a global scale, applies strategic smarts to operational delivery and financial management. Recognized as one of the PharmaVoice 100, some of the industry’s most inspiring people, awarded in the “Change Agent” category.
Nithiyanandhan-Ananthakrishnan-1
Nithiya Ananthakrishnan

Senior Vice President, Biometrics

Visionary executive with a distinguished track-record fostering an environment of continuous innovation and growth through people-centric strategies. Data sciences leader focused on data analysis, visualization, and solutions to solve key issues in clinical trials. On a personal level, deeply committed to supporting educational excellence, particularly for underprivileged children.
Teresa-Pokladowski-300x300
Teresa Pokladowski

Regional Vice President, Clinical Business Solutions, North America

Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management.
Sheila-Antonio
Sheila Antonio

Vice President, Clinical Data Management

Sheila Antonio is the Vice President of Global Data Management at Precision for Medicine. She has more than 25 years of clinical research industry experience in Clinical Data Management. Sheila is well-known as a highly driven technical subject matter expert for managing clinical trial data, SAS programming, and EDC database design and development. She has been a key leader at various contract research organizations (CROs) in developing the mission, values, and strategic goals to create efficient and driven Clinical Data Management teams. Sheila develops programs that focus on thorough technical trainings, as well as effective and positive communications which lead to overall data quality improvements and successful team collaboration.